Inhibition of Human Tumor Growth in Mice by an Oncolytic Herpes Simplex Virus Designed to Target Solely HER-2-positive Cells

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0812268106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Oncolytic Herpes Virus Retargeted to HER-2

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Construction and Properties of a Herpes Simplex Virus 1 Designed to Enter Cells Solely via the IL-13 2 Receptor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Inhibition of Herpes Simplex Virus Type 2 Growth by Phosphorothioate Oligodeoxynucleotides.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

Anti-Tumor Effect of Oncolytic Herpes Simplex Virus G47delta on Human Nasopharyngeal Carcinoma

Chinese Journal of Cancer
2011English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Inhibition of Herpes Simplex Virus Type 2 Replication by Thymidine

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy